Prostalyn

product on market Capsule Princess Lifestyle Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Saw palmetto and stinging nettle have moderate evidence for supporting prostate health and urinary function. Astragalus and lycium are often used for general wellness, though clinical evidence for their specific efficacy in this formula is limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Prostalyn
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
Botanical
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Stinging Nettle
500 mg
310 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Trichosanthes
50 mg
45 mg
Market median: 470.0mg (230 products) 9 studies (A:3, B:3)
Lycium
45 mg
Pygeum
40 mg

Other Ingredients

Gelatin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: As a dietary supplement. Take 2-3 capsules twice daily.

Warnings & Precautions

WARNING: Keep out of reach of children.

Do not use if outer seal band or inner safety seal is missing or damaged.

Formulation Notes

Naturally supports for prostate health*

Additional Information

Store in a cool dry place.

MADE IN USA

Nhiep Ho Tuyen

ITEM#90004 04

Metadata

Product Details

UPC / SKU6 87729 00004 9
DSLD Entry Date2012-10-01
Product TypeBotanical
FormCapsule
DSLD ID12242
Data Updated2026-04-11
Research

Research Evidence

35
Research Sources
52
Avg Quality
15
Meta Analysis
11
Systematic Review
7
Rct
1
Narrative Review
1
Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021 PubMed DOI
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021 PubMed DOI
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019 PubMed DOI
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020 PubMed DOI
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012 PubMed DOI
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025 PubMed DOI
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019 PubMed DOI
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009 PubMed DOI
View all evidence for Saw Palmetto →
Compare

Similar Products

View all Saw Palmetto products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.